Affordable Access

[The safety and immunogenicity of an heptavalent pneumococcal polysaccharide conjugate vaccine (Prevenar) administered in association with a whole-cell pertussis-based pediatric combination vaccine (DTP-IPV/PRP-T) to French infants with a two-, three-, and four-month schedule].

Authors
  • Reinert, P
  • Guy, M
  • Girier, B
  • Szelechowski, B
  • Baudoin, B
  • Deberdt, P
  • Wollner, A
  • Kemeny, G
  • Amzallag, M
  • Moat, C
  • Szelechowski, C
  • Villain-Lemoine, H
  • Bouhanna, C-A
  • Laudat, F
Type
Published Article
Journal
Archives de Pédiatrie
Publisher
Elsevier
Publication Date
Dec 01, 2003
Volume
10
Issue
12
Pages
1048–1055
Identifiers
PMID: 14643532
Source
Medline
License
Unknown

Abstract

The heptavalent pneumococcal conjugate vaccine is immunogenic when administered at 2, 3 and 4 months. PREVENAR can be administered simultaneously with the DTP-IPV/Hib combination vaccine.

Report this publication

Statistics

Seen <100 times